122 related articles for article (PubMed ID: 17707459)
1. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
Yang G; Addai J; Wheeler TM; Frolov A; Miles BJ; Kadmon D; Thompson TC
Hum Pathol; 2007 Nov; 38(11):1688-95. PubMed ID: 17707459
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
Tahir SA; Yang G; Goltsov AA; Watanabe M; Tabata K; Addai J; Fattah el MA; Kadmon D; Thompson TC
Cancer Res; 2008 Feb; 68(3):731-9. PubMed ID: 18245473
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
Li L; Yang G; Ebara S; Satoh T; Nasu Y; Timme TL; Ren C; Wang J; Tahir SA; Thompson TC
Cancer Res; 2001 Jun; 61(11):4386-92. PubMed ID: 11389065
[TBL] [Abstract][Full Text] [Related]
4. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas.
Barresi V; Cerasoli S; Tuccari G
Neuropathology; 2008 Oct; 28(5):472-8. PubMed ID: 18282163
[TBL] [Abstract][Full Text] [Related]
5. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer.
Ohta S; Wada H; Nakazaki T; Maeda Y; Nobori T; Shiku H; Nakamura S; Nagakawa O; Furuya Y; Fuse H
Anticancer Res; 2002; 22(5):2991-6. PubMed ID: 12530031
[TBL] [Abstract][Full Text] [Related]
7. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma.
Ayala GE; Dai H; Tahir SA; Li R; Timme T; Ittmann M; Frolov A; Wheeler TM; Rowley D; Thompson TC
Cancer Res; 2006 May; 66(10):5159-64. PubMed ID: 16707439
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells.
Palozza P; Sestito R; Picci N; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2008 Nov; 29(11):2153-61. PubMed ID: 18635524
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor expression and angiogenesis in human prostate carcinoma.
Abdulkadir SA; Carvalhal GF; Kaleem Z; Kisiel W; Humphrey PA; Catalona WJ; Milbrandt J
Hum Pathol; 2000 Apr; 31(4):443-7. PubMed ID: 10821491
[TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.
Papadopoulos I; Sivridis E; Giatromanolaki A; Koukourakis MI
Clin Cancer Res; 2001 Jun; 7(6):1533-8. PubMed ID: 11410487
[TBL] [Abstract][Full Text] [Related]
12. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer.
Wang W; Bergh A; Damber JE
Clin Cancer Res; 2005 May; 11(9):3250-6. PubMed ID: 15867220
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated angiogenesis in prostate cancer.
Fregene TA; Khanuja PS; Noto AC; Gehani SK; Van Egmont EM; Luz DA; Pienta KJ
Anticancer Res; 1993; 13(6B):2377-81. PubMed ID: 7510938
[TBL] [Abstract][Full Text] [Related]
15. Identification of neovasculature using nestin in colorectal cancer.
Teranishi N; Naito Z; Ishiwata T; Tanaka N; Furukawa K; Seya T; Shinji S; Tajiri T
Int J Oncol; 2007 Mar; 30(3):593-603. PubMed ID: 17273760
[TBL] [Abstract][Full Text] [Related]
16. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS
Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336
[TBL] [Abstract][Full Text] [Related]
17. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
[TBL] [Abstract][Full Text] [Related]
18. Association of a CAV-1 haplotype to familial aggressive prostate cancer.
Haeusler J; Hoegel J; Bachmann N; Herkommer K; Paiss T; Vogel W; Maier C
Prostate; 2005 Oct; 65(2):171-7. PubMed ID: 15948133
[TBL] [Abstract][Full Text] [Related]
19. Expression of endothelial factors in prostate cancer: a possible role of caveolin-1 for tumour progression.
Steiner I; Jung K; Miller K; Stephan C; Erbersdobler A
Oncol Rep; 2012 Feb; 27(2):389-95. PubMed ID: 22075971
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
Tesan T; Gustavsson H; Welén K; Damber JE
BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
